trial
as of 2026-07-01Integrated Care Including Assertive Community Treatment in Early Psychosis
NCTId NCT02037581
at a glance
— · Completed
Enrollment 120 (actual)
Sponsored by Universitätsklinikum Hamburg-Eppendorf
Primary completion 2014-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
120 (actual)
Study type
Interventional
Allocation
Randomized
Model
Factorial
Masking
None
Start
2011-06
Primary completion
2014-12
Eligibility
ALL · 12 Years · 29 Years
Interventions & indications
Sponsors
Universitätsklinikum Hamburg-EppendorfLead Sponsor
Investigators
2
Martin Lambert, ProfessorStudy Director
Anne Karow, Prof.Study Chair
Sites
1 total
Hamburg, Germany
Facts & assertions
4 sourced
Enrollment
120
Phase
NA
Primary Completion Date
2014-12
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
indication
investigator
person